Effectiveness of Moxifloxacin/Dexamethasone for Eye Surgery
Author Information
Author(s): Cesar Ramon G. Espiritu, Mary Ellen A. Sy, Tommee Lynne G. Tayengco
Primary Institution: American Eye Center
Hypothesis
The study aims to evaluate the efficacy and tolerability of a combined moxifloxacin/dexamethasone formulation in preventing postoperative inflammation and infection in Asian patients undergoing phacoemulsification.
Conclusion
The combination of moxifloxacin 0.5% and dexamethasone 0.1% was effective in preventing infection and controlling inflammation after cataract surgery.
Supporting Evidence
- 91.7% of patients had no significant inflammation by day 15.
- No surgery-related infections occurred during the study.
- Mean best-corrected visual acuity improved significantly from baseline.
Takeaway
This study tested a special eye drop to help people after cataract surgery, and it worked well to keep their eyes from getting infected or inflamed.
Methodology
A 15-day, open-label, single-arm trial where patients applied moxifloxacin/dexamethasone eye drops four times daily before and after surgery.
Limitations
The small sample size limits the ability to make statistically significant conclusions about the effectiveness of the medication in preventing postoperative endophthalmitis.
Participant Demographics
The study included 64 patients, predominantly Asian, with a mean age of 68 years.
Statistical Information
P-Value
<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website